Quick search
Advanced search in
Field to searchTerm
Add rule
Download Results
361 research outcomes, page 1 of 37
  • publication . Article . 2016
    Open Access
    Authors:
    E. A. Nikitin; N. N. Sharkunov; V. G. Markaryan; N. A. Lobanova; V. V. Ptushkin;
    Persistent Identifiers
    Publisher: Publishing House ABV Press

    Data on treatment results and long-term toxicity of patients with Hodgkin’s lymphoma in Russian Federation are scarce. We present analysis of the S. P. Botkin Hospital based registry. Six hundreds nine patients were identified since 01.01.2006 to 31.12.2015, among them ...

    Add to ORCIDorcid
  • publication . Article . 2019
    Open Access Russian
    Authors:
    Kovaleva, E. V.; Danzanova, T. Yu.; Sinyukova, G. T.; Gudilina, E. A.; Lepedatu, P. I.; Allahverdieva, G. F.; Zeynalova, P. A.; Semenova, A. A.; Abbasbeyli, F. M.;
    Persistent Identifiers
    Publisher: ABV-press

    Objective. The possibilities of ultrasound elastography of the lymph nodes as an additional technique for the intermediate control of treatment of patients with Hodgkin’s lymphoma are determined. Materials and methods. A prospective study included patients with a diagno...

    Add to ORCIDorcid
  • publication . Article . 2015
    Open Access Russian
    Authors:
    L. M. Meshсheryakova; A. A. Levina; M. M. Tsybulskaya; T. V. Sokolova;
    Persistent Identifiers
    Publisher: ABV-press

    The paper presents the laboratory values by which modern differential diagnosis of anemias can be performed. This takes into account a widerange of laboratory tests, including: serum ferritin, erythrocyte ferritin, serum iron, total serum iron binding capacity, iron tra...

    Add to ORCIDorcid
  • publication . Article . 2015
    Open Access Russian
    Authors:
    Article Editorial;
    Publisher: ABV-press

    Новый препарат компании «Рош» Газива® (обину- тузумаб) для терапии пациентов с хроническим лим- фоцитарным лейкозом (ХЛЛ), которые не лечились ранее, станет доступен на российском рынке с сентя- бря 2015 г

  • publication . Article . 2014
    Open Access Russian
    Authors:
    I. I. Kalinina; U. N. Petrova; O. V. Goronkova; D. D. Baidildina; V. V. Sinitsyna; L. A. Khachatryan; M. A. Maschan; G. A. Klyasova; A. A. Maschan;
    Publisher: ABV-press

    Worldwide distribution of mold fungi and their extremely danger for immune compromise patients makes this issue one of the unsolved problems in modern oncology. Three cases of rare fungal infections in children with hematological malignancies are described. In the first...

  • publication . Article . 2015
    Open Access Russian
    Authors:
    S. V. Semochkin; E. G. Arshanskaya; O. D. Zakharov; A. N. Kotelnikova; S. S. Kulikova; E. V. Ovanesova; Yu. B. Kochkareva; V. L. Ivanova;
    Persistent Identifiers
    Publisher: ABV-press

    Efficacy and safety results of rituximab and bendamustine combination (Scheme BR) in patients with relapsed and refractory chronic lymphocytic leukemia (CLL) are presented. From 01.2012 to 04.2013, the treatment was initiated in 43 patients (21 with relapses are sensiti...

    Add to ORCIDorcid
  • publication . Article . 2014
    Open Access
    Authors:
    Alexander Popov; Grigory Tsaur; Tatiana Verzhbitskaya; Olga Streneva; Egor Shorikov; Leonid Saveliev; Larisa Fechina;
    Persistent Identifiers
    Publisher: American Society of Hematology

    Abstract Abstract 2547 Acute lymphoblastic leukemia (ALL) in children less than 1 year old is the relatively rare disease with specific biological features and poor outcome. It is also characterized by high incidence of MLL gene rearrangements. Immunophenotype of infant...

    Add to ORCIDorcid
  • publication . Article . 2015
    Open Access Russian
    Authors:
    G. D. Petrova; T. Z. Chernyavskaya; N. V. Gorbunova; V. N. Kostrykina; V. A. Doronin; K. N. Melkova;
    Persistent Identifiers
    Publisher: ABV-press

    The development of dose-limiting toxicities, including myelotoxicity, can significantly limit cytostatic therapy of malignant tumors. Neutropenia associated with high risk of febrile neutropenia (FN) and infectious complications that may interfere with therapy intensity...

    Add to ORCIDorcid
  • publication . Article . 2020
    Open Access
    Authors:
    V. B. Larionova; A. V. Snegovoy;
    Persistent Identifiers
    Publisher: Publishing House ABV Press

    Background. In modern oncohematology achieved notable success due to the intensification and development of new chemotherapy regimens. However, the side effects of anticancer drugs, due to low selectivity of most of them, are a serious limitation to achieve their maxima...

    Add to ORCIDorcid
  • publication . Article . 2018
    Open Access
    Authors:
    Novikova, A. A.; Klyasova, G. A.; Gribanova, E. O.; Okhmat, V. A.; Ryzhko, V. V.; Savchenko, V. G.;
    Persistent Identifiers
    Publisher: Publishing House ABV Press

    The aim of the study was to evaluate the profile and risk factors for acquisition of infections in patients with de novo multiple myeloma (MM) on the 1st chemotherapy cycle (CC).Materials and methods. Study included patients with de novo MM undergoing chemotherapy from ...

    Add to ORCIDorcid
361 research outcomes, page 1 of 37